Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Dare Bioscience, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +2 vs. Q4 2021
- Shares held
- 6.64M
- −230.3K (−3.4%) vs. Q4 2021
- Total value
- $9.89M
- −$3.85M (−28.0%) vs. Q4 2021
- New holders
- 12
- 12 more added
- Sold out
- 10
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 146 | $0 | 0.00% | −67,014−99.8% | Reduced |
| Tortoise Investment Management, LLC | 750 | $1.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 881 | $1.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 1,000 | $1.49K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 2,400 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,472 | $4.00K | 0.00% | +2,039+470.9% | Added |
| UBS Group AG | 5,265 | $8.00K | 0.00% | −9,865−65.2% | Reduced |
| Victory Capital Management Inc | 11,580 | $13.0K | 0.00% | +882+8.2% | Added |
| Insight Financial Services | 11,400 | $16.0K | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 11,618 | $17.0K | 0.00% | +11,618 | New |
| United Capital Financial Advisers, LLC | 15,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 15,000 | $22.0K | 0.00% | +15,000 | New |
| Advisor Group Holdings, Inc. | 20,763 | $31.0K | 0.00% | +4,000+23.9% | Added |
| Bank of New York Mellon Corp | 22,537 | $34.0K | 0.00% | +22,537 | New |
| CIBC Private Wealth Group, LLC | 25,000 | $37.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 25,835 | $38.0K | 0.02% | +5,151+24.9% | Added |
| Citigroup Inc | 26,540 | $40.0K | 0.00% | +26,540 | New |
| Commonwealth Equity Services, LLC | 27,625 | $41.0K | 0.00% | −3,750−12.0% | Reduced |
| Bank of America Corp | 29,673 | $44.0K | 0.00% | +29,673 | New |
| Raymond James Financial Services Advisors, Inc. | 30,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 30,035 | $45.0K | 0.00% | +7,371+32.5% | Added |
| Buckingham Strategic Partners | 30,000 | $45.0K | 0.00% | +20,000+200.0% | Added |
| Charles Schwab Investment Management Inc | 30,532 | $46.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 41,968 | $62.0K | 0.00% | +41,968 | New |
| Citadel Advisors LLC | 42,378 | $63.0K | 0.00% | +42,378 | New |
| Jane Street Group, LLC | 58,607 | $87.0K | 0.00% | +1,252+2.2% | Added |
| Price T Rowe Associates Inc | 58,600 | $87.0K | 0.00% | +58,600 | New |
| Interwest Venture Management Co | 62,065 | $92.0K | 0.04% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 72,656 | $108.0K | 0.00% | +72,656 | New |
| Marshall Wace, LLP | 73,680 | $110.0K | 0.00% | −1,314,882−94.7% | Reduced |
| Renaissance Technologies LLC | 100,339 | $150.0K | 0.00% | +100,339 | New |
| Gsa Capital Partners LLP | 125,954 | $188.0K | 0.03% | −15,889−11.2% | Reduced |
| Northern Trust Corp | 140,922 | $210.0K | 0.00% | +346+0.2% | Added |
| State Street Corp | 178,810 | $266.0K | 0.00% | +17,480+10.8% | Added |
| Millennium Management LLC | 255,995 | $381.0K | 0.00% | +255,995 | New |
| Soviero Asset Management, LP | 300,000 | $447.0K | 0.11% | +300,000 | New |
| BlackRock Inc. | 602,036 | $897.0K | 0.00% | +234,243+63.7% | Added |
| Geode Capital Management, LLC | 698,533 | $1.04M | 0.00% | +215,915+44.7% | Added |
| Vanguard Group Inc | 3,453,021 | $5.14M | 0.00% | +396,968+13.0% | Added |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −246,612−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −155,128−100.0% | Sold out |
| Founders Financial Securities LLC | 0 | $0 | 0.00% | −103,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −77,313−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −48,384−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −34,400−100.0% | Sold out |
| Paradigm, Strategies in Wealth Management, LLC | 0 | $0 | 0.00% | −22,355−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,617−100.0% | Sold out |
| Edge Wealth Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| NVWM, LLC | 0 | $0 | 0.00% | −520−100.0% | Sold out |